GlassScriptPhysician profile
George A Vassolas
NPI 1679597975
$5,153.06
in general payments reported to CMS, 2019-2025
33 companies · $853 in 2025
The $853 reported for 2025 was more than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,615 · 2020: $302 · 2021: $334 · 2022: $509 · 2023: $775 · 2024: $766 · 2025: $853.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,394.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,393.63 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $531.76 | 2019-2025 | |
| Novartis Pharmaceuticals Corporation | $501.47 | 2019-2025 | |
| Medtronic, INC. | $420.69 | 2022-2025 | Aurora Ev-Icd Mri Surescan, Corevalve Evolut R, Linq II |
| Boehringer Ingelheim Pharmaceuticals, INC. | $413.65 | 2019-2025 | Jardiance |
| Abbott Laboratories | $405.24 | 2019-2025 | Perclose Prostyle |
| Amgen INC. | $309.57 | 2019-2024 | Repatha |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $303.72 | 2019-2025 | Lifevest |
| Astrazeneca Pharmaceuticals LP | $299.44 | 2019-2025 | Wainua, Farxiga |
| Alnylam Pharmaceuticals INC. | $255.21 | 2022-2025 | Onpattro |
| Merck Sharp & Dohme LLC | $222.24 | 2022-2025 | Verquvo, Winrevair |
| Janssen Pharmaceuticals, INC | $208.38 | 2019-2024 | Xarelto |
| E.R. Squibb & Sons, L.L.C. | $191.13 | 2019-2024 | Eliquis, Camzyos |
| Actelion Pharmaceuticals US, INC. | $134.96 | 2022-2025 | Uptravi |
| Boston Scientific Corporation | $116.61 | 2019-2023 | Watchman Access System |
| Medtronic Vascular, INC. | $113.12 | 2019 |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amarin Pharma, INC. | $92.22 | 2019-2022 | |
| Sanofi-Aventis U.S. LLC | $85.91 | 2019-2024 | |
| Regeneron Healthcare Solutions, INC. | $76.95 | 2019-2023 | Evkeeza |
| Scpharmaceuticals INC. | $67.70 | 2023-2025 | |
| Bridgebio Pharma, INC. | $54.27 | 2025 | Attruby |
| Novo Nordisk INC | $48.05 | 2023-2025 | Wegovy |
| Abiomed | $43.25 | 2023-2025 | Impella |
| Terumo Medical Corporation | $40.67 | 2019-2023 | Angio-Seal |
| Chiesi USA, INC. | $34.50 | 2019 | |
| Esperion Therapeutics, INC. | $32.66 | 2021-2024 | Nexletol |
| Medicomp INC | $29.01 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $21.14 | 2024 | |
| Genzyme Corporation | $18.87 | 2023 | |
| Lexicon Pharmaceuticals, INC. | $18.82 | 2023 | Inpefa |
| Kiniksa Pharmaceuticals, LTD. | $18.32 | 2023 | Arcalyst |
| Edwards Lifesciences Corporation | $16.58 | 2020 | |
| Teleflex LLC | $14.48 | 2023 | Manta |
| Philips North America LLC | $12.47 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw George Vassolas listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.